article · Surgery Gastroenterology and Oncology
Background: Metabolic associated fatty liver disease (MAFLD) can significantly increase the prevalence of chronic complications in patients with T2DM. Objectives: to analyse the association between the thyroid hormones and MAFLD in T2DM Egyptian patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21614/sgo-642
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
